Guard Therapeutics International AB (publ) (STO:GUARD)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.500
+0.100 (7.14%)
Jul 24, 2026, 5:29 PM CET

STO:GUARD Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
11.6911.749.929.158.825.96
Research & Development
69.279690.33105.77104.8175.33
Other Operating Expenses
0.18-0.54-0.340.151.290.62
Total Operating Expenses
81.13107.299.91115.07114.9281.9
Operating Income
-80.98-107.2-99.91-115.07-114.92-81.9
Interest Income
0.640.583.852.22.080.02
Interest Expense
-0.64-2.23-0.01-0.45-0-0.15
Total Non-Operating Income (Expense)
-0.01-1.663.841.752.08-0.13
Pretax Income
-80.99-108.85-96.07-113.32-112.84-82.03
Net Income
-80.99-108.85-96.07-113.32-112.84-82.03
Net Income to Common
-80.99-108.85-96.07-113.32-112.84-82.03
Shares Outstanding (Basic)
2018111074
Shares Outstanding (Diluted)
2018111074
Shares Change (YoY)
70.67%61.72%10.82%42.77%57.95%34.53%
EPS (Basic)
-4.07-6.04-8.62-11.26-16.01-18.50
EPS (Diluted)
-4.07-6.04-8.62-11.26-16.01-18.50
Free Cash Flow
-82.35-109.35-94.75-116.05-102.14-77.59
Free Cash Flow Per Share
-4.12-6.06-8.50-11.53-14.49-17.39
EBITDA
-80.98-107.2-99.91-115.07-114.92-81.9
EBIT
-80.98-107.2-99.91-115.07-114.92-81.9